(Q50743867)

English

Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey.

scientific article published in June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

author name string

Siddhesh A Kamat

1

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

Krithika Rajagopalan

2

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

Judith J Stephenson

3

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

Sonalee Agarwal

4

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

publication date

1 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

The Patient: Patient-Centered Outcomes Research

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

2

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

2

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

105-112

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

https://scigraph.springernature.com/pub.10.2165/01312067-200902020-00006

0 references

A questionnaire to assess neurological impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.2165%2F01312067-200902020-00006

21 January 2018

Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.2165%2F01312067-200902020-00006

21 January 2018

Principles of rheumatoid arthritis control

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life in multiple sclerosis: effects of natalizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Which chronic conditions are associated with better or poorer quality of life?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of quality of life measures in multiple sclerosis research.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of multiple sclerosis: a critical overview.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Burden of illness of multiple sclerosis: Part II: Quality of life. The Canadian Burden of Illness Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review about the impact of multiple sclerosis on health-related quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease steps in multiple sclerosis: a simple approach to evaluate disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22273086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/01312067-200902020-00006

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/22273086

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50743867&oldid=1412100189"